Upon this, yet to be peer reviewed, December 15, 2021 Hong Kong paper, Dr Malone suggests Omicron could be a blessing, because the pattern of infection suggests more bronchial than deep lung, explains less severe disease. [1, 2, 4]

Studies are showing infectivity and spread of Omicron is fast, but symptoms are overall mild, less severe, less pathogenic compared to previous variants.

Dr Malone hypothesises that “Omicron may have now evolved to replicate more in our upper respiratory airway, and less in the deep part of our lung tissues due to shifts in receptor specificity. In other diseases, like influenza, replication in upper respiratory airways is associated with less severe disease.”

On Fox News, Laura Ingraham show on Dec 18 Dr Malone states that “Omicron blows right through the vaccines and the triple jabbed”, thus the vaccines are not protective against the highly infectious Omicron variant, but at last count the “number of deaths worldwide to Omicron is less than 10” – meaning the disease is mild. [3, 4]  Case numbers maybe up, but the death numbers do not follow.

On December 22, 2021, the FDA granted EUA for Pfizer’s COVID-19 drug called Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) for the treatment of mild-to-moderate COVID-19 disease in 12+ year olds. The drug should be given early; within 5 days of symptom onset. This makes it the first “approved” treatment before hospitalisation. [1, 2, 3, 4, 5]

“Paxlovid consists of nirmatrelvir, which inhibits a SARS-CoV-2 protein to stop the virus from replicating, and ritonavir, which slows down nirmatrelvir’s breakdown to help it remain in the body for a longer period at higher concentrations.” “Paxlovid is not authorized for use for longer than five consecutive days.”

This follows on from UK govt. approving Merck’s mutagenic drug molnupiravir. [6]  A drug that mutates SARS-CoV-2 creating the potential for someone to shed mutant virus variants for several days.

Australia’s TGA is considering Pfizer’s Paxlovid and Merck’s molnupiravir for provisional registration, and generally they follow what the FDA approve. [7, 8]

The highly transmissible Omicron variant has become prevalent in the population and the CDC updates and shortens recommended isolation and quarantine periods for asymptomatic general population from 10 days to 5 days, and wear a mask.

Two days later CDC quietly revised this guidance to even less restrictive: Exit quarantine after 5-day isolation not only when you are “asymptomatic,” but also when your “symptoms are resolving (without fever for 24 hours)”. [1, 2]

Through the pandemic 40% of “positive cases” of COVID-19 have been asymptomatic, meaning they never develop symptoms, but are diagnosed as positive and “infectious” via a flawed PCR test.  Though a study of 10 million people demonstrated that transmission does not occur to any significance from an asymptomatic person.

With 91.9% vaccination coverage across Australia, the news reports that the COVID-19 vaccines have led to at least 79,000 adverse reactions, as claimed through the September 6th no-fault, tax payer funded, compensation scheme.

The injured plantiffs claiming under $20,000 must provide evidence from their physician, for more serious conditions leading to claims over $20,000, they require a review by a panel of legal experts. [1]

ABS report Australian population of 25.7 million as of June 2021, of which there were 2.6 million children aged 0-15 years, leaving 23.1 million Australians aged 16 years and over.  With the reported 91.9% double vaccinated, that is 21.26 million Australians, of those 79,000 claimed serious adverse injuries which is a rate of 0.37% of those vaccinated, 3700 times higher that the “1 in a million” rare serious side effect claimed by authorities. [2, 3, 4, 5]

TGA received 129,732 (23%) post-vaccine adverse event reports into their pharmacovigilance system up to September 2021, which means 60% of these reports have resulted in a potential payout.

The number of adverse reports for all medicines as received by September 2021 is 27 times higher than 2017 reports, as calculated from to TGA’s own data. Yet TGA admits their system is under reported, “lack key information” and there is “no denominator”.

Throughout the past 2 years frontline doctors globally have been using and promoting, where they can, early treatments for COVID-19.  But you won’t hear this on mainstream media or by the government health departments.

Their strategy is to prevent hospitalisation has been to hit it hard, hit it early, and to reduce hospital stay they are using a range of drugs and nutraceuticals that all have a role to play in the symptom progression of COVID-19 – anti-viral, anti-inflammatory, anti-coagulant.

• Ivermectin timeline
• Hydroxychloroquine timeline
• Critical care information